The association between CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) and Melanoma-Astrocytoma Syndrome is well established and manually curated, with its 4 contributing sources — 3 of them expert-curated — recording a known molecular basis, pathogenic variants, and a susceptibility locus.
Sources4
Clinical variants135
Symptoms4
Compounds0
Trials0
Publications4
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.